Literature DB >> 26742998

Cancer statistics, 2016.

Rebecca L Siegel1, Kimberly D Miller2, Ahmedin Jemal3.   

Abstract

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.
© 2016 American Cancer Society.

Entities:  

Keywords:  cancer cases; cancer statistics; death rates; incidence; mortality; survival; trends

Mesh:

Year:  2016        PMID: 26742998     DOI: 10.3322/caac.21332

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  2000 in total

1.  Exploratory metabolomic study to identify blood-based biomarkers as a potential screen for colorectal cancer.

Authors:  Isaac Asante; Hua Pei; Eugene Zhou; Siyu Liu; Darryl Chui; EunJeong Yoo; David V Conti; Stan G Louie
Journal:  Mol Omics       Date:  2019-02-11

2.  Association of Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns in the United States From 2007 to 2014.

Authors:  Jae Heon Kim; Shufeng Li; Yash Khandwala; Kyung Jin Chung; Hyung Keun Park; Benjamin I Chung
Journal:  JAMA Surg       Date:  2019-03-01       Impact factor: 14.766

3.  A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer.

Authors:  Weihua Hou; Qingyun Yuan; Xingxing Yuan; Yuxiong Wang; Wei Mo; Huijie Wang; Min Yu
Journal:  Invest New Drugs       Date:  2018-12-04       Impact factor: 3.850

4.  Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model.

Authors:  Sweta K Gupta; Elisa A Torrico Guzmán; Samantha A Meenach
Journal:  Int J Cancer       Date:  2017-08-18       Impact factor: 7.396

5.  Testicular Cancer on the Web-an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines?

Authors:  Pia Paffenholz; Johannes Salem; Hendrik Borgmann; Tim Nestler; David Pfister; Christian Ruf; Igor Tsaur; Axel Haferkamp; Axel Heidenreich
Journal:  J Cancer Educ       Date:  2018-12       Impact factor: 2.037

Review 6.  Prevention of Chemotherapy Induced Cardiomyopathy.

Authors:  David L Payne; Anju Nohria
Journal:  Curr Heart Fail Rep       Date:  2017-10

Review 7.  Emerging Roles of Electrospun Nanofibers in Cancer Research.

Authors:  Shixuan Chen; Sunil Kumar Boda; Surinder K Batra; Xiaoran Li; Jingwei Xie
Journal:  Adv Healthc Mater       Date:  2017-12-06       Impact factor: 9.933

8.  Hsp90 inhibitor sensitizes TRAIL-mediated apoptosis via chop-dependent DR5 upregulation in colon cancer cells.

Authors:  Zhicheng Yao; Ang Chen; Xin Li; Zhiyong Zhu; Xin Jiang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

9.  Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review.

Authors:  Paul L Feingold; Nicholas D Klemen; Mei Li M Kwong; Barry Hashimoto; Udo Rudloff
Journal:  Int J Hyperthermia       Date:  2017-12-07       Impact factor: 3.914

10.  How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.

Authors:  Anne M Muehe; Ashok J Theruvath; Lillian Lai; Maryam Aghighi; Andrew Quon; Samantha J Holdsworth; Jia Wang; Sandra Luna-Fineman; Neyssa Marina; Ranjana Advani; Jarrett Rosenberg; Heike E Daldrup-Link
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.